NDC 49281-126 – Fluzone High Dose Northern Hemisphere

Influenza A Virus A/switzerland/6849/2025 Ivr-278 (h1n1) Antigen (formaldehyde Inactivated) 60 ug/.5mL; Influenza A Virus A/michigan/105/2025 San-049a (h3n2)… · Injection, Suspension · Intramuscular

Vaccine

Product NDC49281-126

Product details

Brand name
Fluzone High Dose Northern Hemisphere
Generic name
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (A/MISSOURI/11/2025 PDM09-LIKE VIRUS) (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)
Labeler
Sanofi Vaccines US Inc.
Dosage form
Injection, Suspension
Route
Intramuscular
Marketing category
BLA · BLA103914
Marketed since
July 2, 2026
Marketing end
June 30, 2027

Active ingredients

Package NDC codes (1)

Package NDCDescriptionSince
49281-126-655 SYRINGE, GLASS in 1 PACKAGE (49281-126-65) / .5 mL in 1 SYRINGE, GLASS (49281-126-88)Jul 2, 2026

Other Fluzone High Dose Northern Hemisphere products